CCL11 and allergic disease: Most studies assessing the plasma/serum concentration or tissue expression of eotaxins concern changes after treatment in the course of various allergic diseases (i.e., asthma, atopic dermatitis, eosinophilic esophagitis, and chronic rhinosinusitis).